Fixed-dose combination oral tablets combining aspirin and clopidogrel bisulfate, manufactured by pharmaceutical firms for supply to hospitals, cardiology clinics, and wholesale distributors. Procured by healthcare facilities for cardiovascular risk management in patients with acute coronary syndromes and post-stent implantation.